3P innovation Ltd

3P innovation Ltd: Precision-Engineered Automation Solutions for Pharmaceutical and Industrial Manufacturing Since 2006

3P innovation Ltd is a UK-based engineering company specialising in custom automation and pharmaceutical equipment for the pharmaceutical, medical device, FMCG, and confectionery sectors. Founded in 2006 by a group of like-minded engineers with a passion for high-performance machinery and innovation, the company has grown to employ a large, multi-disciplined team of professional engineers with a combined experience base of over 1,000 years.

Specialists at 3P innovation are named on over 300 patents across a broad spectrum of products and industry sectors. The company’s name reflects its core philosophy — considering Product, Process, and Production simultaneously — ensuring manufacturing constraints and scale-up risks are addressed before production begins. 3P innovation is headquartered in Warwick, United Kingdom, with a purpose-built 60,000 sq ft facility (expanded through a £5 million investment) supporting design, build, test, and commissioning of complex automation systems. The company serves clients worldwide across Europe, North America, Asia, and beyond.

3P innovation at interpack Düsseldorf 2026: Presenting Pharma Equipment and Custom Automation to Global Industry

interpack Düsseldorf, the world’s leading trade fair for packaging technology, provides 3P innovation with a strategic platform to present its pharmaceutical equipment and custom automation solutions to global pharmaceutical manufacturers, CDMOs, medical device companies, and FMCG producers.

As a two-time Queen’s Award winner (Innovation 2020, International Trade 2021) and Princess Royal Training Award recipient (2021), 3P innovation will showcase its proprietary platforms including Fill2Weight micro-dosing technology, R500 and R1000 robotic capsule and container fillers, F2V liquid fill-finish platform, and aseptic micro-auger technology. The company’s presence focuses on demonstrating how its proof-of-principle methodology de-risks innovation, tests feasibility early, and reduces time to market for regulated products.

Proprietary Pharma Equipment Platforms: Fill2Weight, R500, R1000, F2V, and Micro-Auger Technology

3P innovation has developed a portfolio of proprietary pharmaceutical equipment platforms designed for scalability from development through commercial production:

Fill2Weight Micro-Dosing Technology (2008) : Designed to meet increasing requirements for high-accuracy, precision powder filling in a sterile environment. Fills to target weight, dynamically measuring and recording the dispensed weight of all doses. Awarded the Queen’s Award for Enterprise in Innovation (2020) — recognised for addressing the challenges of getting powders to flow and dispense accurately for pharmaceutical and medical device products. This technology was achieved by combining several different technologies in one solution, creating a highly innovative system capable of filling practically any powder into a very diverse range of containers.

R500 Robotic Capsule and Container Filler (2016) : Incorporating Fill2Weight technology, the R500 is the world’s fastest gravimetric powder micro-dosing technology. Fills capsules, containers, and devices on the same machine with rapid changeover and scalable, high-speed filling. Handles the most difficult and challenging powders, including spray-dried, cohesive, sticky powders, pure APIs, and delicate biologics.

R1000 Robotic Capsule and Device Filler (2019) : Integrates two Fill2Weight technology heads, capable of handling the most challenging powders with the worst flow properties — including spray-dried powders, pure API, micronised, blended, and bulk lyophilised powders — twice as fast as the R500, whilst maintaining the same level of accuracy and control. Fully automated, GMP compliant, and suitable for sterile manufacture.

F2V Liquid Fill-Finish Platform (2020) : A liquid fill-finish platform perfect for lab-scale and clinical manufacture thanks to its bench-top format. Designed for use in both pre-clinical and clinical manufacturing environments, complying with cGMP guidelines and suitable for use in existing containment isolators, RABS, and sterile environments. Fills cartridges, syringes, vials, bottles, and custom containers (including diagnostics) in the same machine, with a fast changeover time of less than five minutes.

Aseptic Micro-Auger Technology (2017) : Launched for precise powder filling and designed to meet increasing demand for high-accuracy in clean and sterile environments. Offers fill weight flexibility and the ability to fill a wide variety of devices including reconstitutable injection devices, vials, cartridges, syringes, inhalers, and sachets.

cryoFIL® Technology (2026) : The company’s latest innovation, for which 3P innovation won the King’s Award for Enterprise in Innovation (announced May 6, 2026). cryoFIL technology addresses advanced challenges in pharmaceutical and cell therapy manufacturing.

As 3P innovation states: “Our proprietary pharma equipment platforms – designed for scalability from development through commercial use – enable smoother transitions, fewer change-overs and faster integration, helping clients move from concept to market with greater confidence and speed.”

Custom Automation: Bespoke High-Performance Machinery for Diverse Industries

Beyond proprietary platforms, 3P innovation designs bespoke high-performance machinery for pharmaceutical, medical device, FMCG, and confectionery sectors. Custom automation capabilities include:

Confectionery automation (Mondelez collaboration) : 3P innovation worked closely with Mondelez to design and develop a highly innovative solution that tightly controls the conditions of chocolate throughout the manufacturing process. This solution was essential in ensuring smooth, evenly-coloured chocolate and satisfying snap when biting — demonstrating the company’s ability to apply pharmaceutical-grade precision to FMCG applications.

Medical device assembly and testing : Consort Medical, a medical device development company, reported: “3P listened to our needs and responded with flexible, precise and user-friendly machines that have been invaluable in helping us to understand and develop our device more effectively. Our operators have all commented on just how easy and intuitive it is to use!”

Pharmaceutical processing : Aseptic filling, powder handling, liquid filling, container handling, and inspection systems for regulated environments.

FMCG and consumer goods : High-speed assembly, packaging, and quality assurance systems for fast-moving consumer goods requiring precision and reliability.

As a client testimonial from Steven Hay, Senior Industrialisation Engineer, states: “We have always found it a pleasure to deal with 3P due to the friendliness of staff, responsiveness, willingness to accommodate requests, flexibility, efficient planning, and execution.”

Proof-of-Principle Methodology: De-Risking Innovation and Accelerating Time to Market

3P innovation applies a proof-of-principle methodology from the outset to de-risk innovation, test feasibility early, and reduce time to market. Key principles include:

Product-Process-Production simultaneous consideration : The “3P” concept ensures manufacturing constraints and scale-up risks are addressed before production begins — preventing downstream delays that plague conventional equipment procurement.

Feasibility testing before full development : Early-stage testing validates that proposed solutions work with actual products under realistic conditions, avoiding late-stage surprises.

Scalability addressed early : Systems designed to work at lab scale, clinical scale, and commercial scale — with technology transfer pathways identified before development begins.

Regulatory compliance built in, not bolted on : Compliance-centric design philosophy ensures GMP, cGMP, and sterile manufacturing requirements are embedded from concept stage.

This approach enables clients to innovate confidently while maintaining the exacting standards critical applications demand. The company’s process-driven approach reduces risk and accelerates time to market, giving clients the confidence to innovate and achieve manufacturing excellence.

For pharmaceutical manufacturers, this methodology translates to faster technology transfer from R&D to production, reduced regulatory submission risk, and lower total project cost — avoiding expensive redesigns or requalification late in development.

Key Capabilities: Scaling Efficiently, Maintaining Precision, Ensuring Compliance

3P innovation structures its value proposition around three core capability areas:

Scaling Efficiently : Proven methods for successful R&D-to-commercial production. Consistent process performance across production phases. Scale-up risks addressed before production begins. Proprietary platforms designed for scalability from development through commercial use.

Maintaining Precision : Meticulous attention to engineering detail. Solutions delivering robust, high-precision automation processes. Exacting standards for critical applications. Fill2Weight technology fills to target weight with dynamic measurement and recording of all doses.

Ensuring Compliance : Comprehensive knowledge of industry-specific regulations (pharmaceutical, GMP, cGMP, sterile manufacturing). Compliance-centric design philosophy. Strategic approaches to quality and product integrity. Equipment suitable for sterile manufacture, containment isolators, RABS, and cleanroom environments.

As the company states: “Our approach uniquely combines deep engineering expertise with the flexibility to apply custom automation precisely to client needs across both bespoke projects and portfolio platforms.”

History and Growth: From Founding (2006) to Employee Ownership (2021) to £5M Facility Expansion

3P innovation’s growth trajectory demonstrates sustained investment and long-term thinking:

2006 : 3P innovation founded by Tom Bailey and Dave Seaward, sharing a passion for high-performance production machinery and understanding the symbiotic relationship between products and the processes by which they are made — the concept of 3P (Product, Process, Production).

2008 : Fill2Weight micro-dosing technology launched.

2009 : Recognised as one of the UK’s fastest growing companies (top 1%).

2010 : Moved to larger premises in Warwick.

2016 : R500 robotic capsule and container filler launched.

2017 : Aseptic Micro-Auger technology launched.

2018 : Completed new 30,000 sq ft purpose-built facility at Tournament Fields near Warwick.

2019 : R1000 robotic capsule and device filler launched.

2020 : Awarded Queen’s Award for Enterprise in Innovation for Fill2Weight technology. F2V liquid fill-finish platform launched.

2021 : Became an Employee-Owned company — founders Tom Bailey and Dave Seaward transitioning ownership to employees as the best successors for ongoing and long-term ownership. Awarded second Queen’s Award for Enterprise in International Trade. Awarded Princess Royal Training Award for Graduate Development Programme.

2022 : £5 million investment in a second eco-friendly 30,000 sq ft purpose-built facility, bringing total premises to 60,000 sq ft of office and workshop space — allowing workforce to double in size. Extended brand to differentiate Pharma Equipment, Custom Automation, and Customer Care divisions.

2024 : Continued growth and development.

2026 : Won King’s Award for Enterprise in Innovation for cryoFIL® technology (announced May 6, 2026).

The transition to Employee Ownership in 2021 secured 3P innovation’s long-term future for the benefit of both customers and employees — ensuring continuity of engineering expertise, customer relationships, and company values beyond the original founders.

3P innovation’s award-winning undergraduate development scheme has long-term relationships with leading engineering universities. Combined with more experienced engineers, this powerful mix enables the company to embrace and apply new technologies and best practice throughout its work.

Global Reach: Serving Pharmaceutical and Industrial Clients Worldwide

Although headquartered in the UK, 3P innovation serves clients worldwide — including Europe, North America, and Asia — delivering solutions for global manufacturing operations. The company offers international supply, installation, support, and after-sales services whether production is in the UK or overseas. Between 2017 and 2020, 40% of new customers were international, reflecting successful penetration of new markets and a diversified portfolio of clients — recognised through the Queen’s Award for International Trade (2021).

Customer Service: Direct Access to Original Design Engineers

3P innovation distinguishes itself through attentive customer service and technical support. When challenges arise, the dedicated support team provides direct access to your equipment’s original design engineers — ensuring swift resolution with the responsiveness that sets the company apart. As 3P innovation states: “True partnership defines our relationship from concept through lifetime optimisation.”

The company’s Customer Care division, established in 2022, focuses specifically on after-sales support, spare parts, training, and long-term equipment optimisation — ensuring that clients receive ongoing value throughout the equipment lifecycle.

Engaging with 3P innovation at interpack Düsseldorf 2026

At interpack Düsseldorf 2026, 3P innovation representatives will present Fill2Weight technology, R500/R1000 robotic fillers, F2V liquid fill-finish platform, and custom automation capabilities. The exhibit is designed for technical dialogue with pharmaceutical manufacturers, CDMOs, medical device companies, and FMCG producers seeking precision automation for regulated environments. All formal business inquiries are directed through 3P innovation’s established B2B channels.

Professional Resources and Further Information

For strategic context on the world’s leading packaging technology trade fair, review the interpack Düsseldorf Trade Fair Overview.
To explore 3P innovation’s complete pharma equipment portfolio and custom automation capabilities, visit the official 3P innovation website.

Frequently Discussed Topics Regarding 3P innovation Ltd

• What is 3P innovation’s core business and history?
  3P innovation designs precision-engineered automation solutions for pharmaceutical and industrial manufacturing. Founded in 2006, the company has grown to employ engineers with over 1,000 years combined experience, named on over 300 patents. Two-time Queen’s Award winner (Innovation 2020, International Trade 2021), Princess Royal Training Award recipient (2021), and King’s Award winner (2026).
• What does the “3P” in 3P innovation stand for?
  Product, Process, and Production — the company’s core philosophy of considering all three simultaneously to prevent downstream delays and scale-up risks.
• What is Fill2Weight technology?
  High-accuracy, precision powder micro-dosing technology filling to target weight with dynamic measurement and recording of all doses. Awarded Queen’s Award for Innovation 2020. Capable of filling practically any powder into a diverse range of containers.
• What are the R500 and R1000 machines?
  Robotic capsule and container fillers incorporating Fill2Weight technology. R500 is the world’s fastest gravimetric powder micro-dosing technology. R1000 integrates two Fill2Weight heads and operates twice as fast as R500 while maintaining accuracy and control.
• What is the F2V platform?
  Liquid fill-finish platform for lab-scale and clinical manufacture — bench-top format, cGMP compliant, fills cartridges, syringes, vials, bottles, and custom containers with less than five-minute changeover.
• What industries does 3P innovation serve?
  Pharmaceutical manufacturers, CDMOs, medical device companies, FMCG, and confectionery sectors (including Mondelez for chocolate processing).
• Is 3P innovation an employee-owned company?
  Yes. In 2021, founders transitioned ownership to employees, securing the company’s long-term future for the benefit of customers and employees.
• Why is interpack a strategic platform for 3P innovation?
  interpack is the world’s leading packaging technology trade fair, attracting global pharmaceutical and FMCG manufacturers seeking precision automation for regulated environments — exactly 3P innovation’s target market with its proprietary pharma equipment and custom automation capabilities.
• How can a pharmaceutical manufacturer partner with 3P innovation?
  Professional inquiries should be directed through the official B2B channels on the 3P innovation website or by connecting with the team at interpack Düsseldorf 2026.